AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS - Spain 

Ranking results:

Past rankings:

Subject specific rankings are not yet available..

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 1
As coordinator: 0
As participant: 1
Sole participant: 0
Coordinator / Participant Ratio: 0*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2011 0 2.997.196 116.452 1

Networking:

Partners:

Institution:Projects [No]:
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE4
NOVARTIS PHARMA4
AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN3
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM3
HEALTH PRODUCTS REGULATORY AUTHORITY3
HL7 INTERNATIONAL FONDATION3
MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY3
PFIZER LIMITED3
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL3
ABBVIE INC2
AGENCIJA ZA LIJEKOVE I MEDICINSKE PROIZVODE2
AGES OSTERREICHISCHE AGENTUR FUR GESUNDHEIT UND ERNAHRUNGSSICHERHEIT2
BAYER2
BETH ISRAEL DEACONESS MEDICAL CENTER INC NON PROFIT CORPORATION2
CELGENE MANAGEMENT SARL2
CHARITE UNIVERSITAETSMEDIZIN BERLIN2
DATAWIZARD2
EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH2
EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION2
EUROPEAN HEMATOLOGY ASSOCIATION2
EUROPEAN RESEARCH INITIATIVE ON CLL EV2
FEDERAL AGENCY FOR MEDICINES AND HEALTH PRODUCTS2
FONDAZIONE ITALIANA SINDROMI MIELODISPLASTICHE ETS2
FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS2
FUNDACION HOSPITAL LA FE2
FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON2
GENOME RESEARCH2
GMV SOLUCIONES GLOBALES INTERNET SAU2
GPOH GEMEINNUTZIGE2
GROUPE FRANCOPHONE DES MYELODYSPLASIES2
INFARMED AUTORIDADE NACIONAL DO MEDICAMENTO E PRODUTOS DA SAUDE IP2
INSTYTUT LOGISTYKI I MAGAZYNOWANIA2
INTERNATIONAL HEALTH TERMINOLOGY STANDARDS DEVELOPMENT ORGANISATION2
LAAKEALAN TURVALLISUUSJA KEHITTAMISKESKUS2
LAKEMEDELSVERKET2
LEUKANET EV2
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN2
MASARYKOVA UNIVERZITA2
MEDISAPIENS OY2
MENARINI RICERCHE2
MLL MUNCHNER LEUKAMIELABOR2
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE2
OSPEDALE PEDIATRICO BAMBINO GESU2
REGIONE LOMBARDIA2
SPMS SERVICOS PARTILHADOS DO MINISTERIO DA SAUDE EPE2
STATENS LEGEMIDDELVERK2
STICHTING VUMC2
STIFTUNG ELN FOUNDATION2
THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA2
THE LYMPHOMA STUDY ASSOCIATION2
UNIVERSIDAD DE NAVARRA2
UNIVERSITA DEGLI STUDI DI TORINO2
UNIVERSITAET ULM2
UNIVERSITY OF BOLOGNA2
UNIVERSITY OF HELSINKI2
UNIVERSITY OF NEWCASTLE UPON TYNE2
VIB VZW2
AGENCE NATIONALE DE SECURITE DU MEDICAMENT ET DES PRODUITS DE SANTE1
AGENZIA ITALIANA DEL FARMACO1
AKERSHUS UNIVERSITETSSYKEHUS HF1
AMGEN1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASTRAZENECA1
AZIENDA OSPEDALIERA UNIVERSITARIA FEDERICO II1
AZIENDA REGIONALE PER L'INNOVAZIONEE GLI ACQUISTI1
BARTS AND THE LONDON NHS TRUST1
BAYER PHARMA1
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL1
COMITE EUROPEEN DE COORDINATION DES INDUSTRIES RADIOLOGIQUES ELECTROMEDICALES ET D INFORMATIQUE DE SANTE AISBL1
CSL BEHRING1
CUSTODIX NV1
DATAPHARM LIMITED1
DEPARTMENT OF HEALTH1
DEUTSCHES ZENTRUM FUR LUFT UND RAUMFAHRT EV1
DRUG SAFETY RESEARCH TRUST1
ECHALLIANCE COMPANY LIMITED BY GUARANTEE1
ELGA1
ELI LILLY AND COMPANY1
EMPIRICA GESELLSCHAFT FUER KOMMUNIKATIONS UND TECHNOLOGIE FORSCHUNG MBH1
EUROPEAN ALLIANCE FOR PERSONALISED MEDICINE ASBL1
EUROPEAN HEALTH TELEMATICS ASSOCIATION1
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL1
F HOFFMANNLA ROCHE1
FONDAZIONE MARIO NEGRI SUDCENTRO DI RICERCHE FARMACOLOGICHE EB IOMEDICHE1
FONDAZIONE SCIENTIFICA SIMGONLUS1
FORUM DES PATIENTS EUROPEENS1
FRISQ HOLDING AB1
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON1
GNOMON PLIROPHORIKIS AE1
GROUP FOR RESEARCH ON ADULT ACUTE LYMPHOBLASTIC LEUKEMIA1
GRUNENTHAL1
GUARDTIME OU1
HARVARD MEDICAL SCHOOL1
HEINRICHHEINEUNIVERSITAET DUESSELDORF1
HIMSS EUROPE1
HRVATSKI ZAVOD ZA ZDRAVSTVENO OSIGURANJE1
IDMP11
ILEKTRONIKI DIAKYVERNISI KOINONIKISASFALISIS AE1
INDRA SISTEMAS S A1
INTEGRATING THE HEALTHCARE ENTERPRISEEUROPE AISBL1

Constancy:

Total number of partners: 225
Partner loyalty:
Frequent Partner: (> 2 projects): 29
Rare Partner: 196
Frequent / Rare Partner Ratio: 0.15

Project overview:

Start dateProjectacronymrolefundingpartners
2011-10-01Safety Evaluation of Adverse Reactions in Diabetes SAFEGUARDparticipant2.997.19617

Alias institution names:

  • AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS